Key Contacts
Recognition
Insights & News
- Client News
PTC Therapeutics Completes $550 Million Convertible Notes Offering
WilmerHale advised PTC Therapeutics, Inc., a global biopharmaceutical company, in the offering of $550 million of 0% Convertible Senior Notes due 2031 pursuant to Rule 144A under the Securities Act of 1933, as amended.
- Recognition
The Legal 500 United States 2026 Recognizes WilmerHale Lawyers and Practice Areas
- Client News